J.D. Medlock Profile picture
Editor @TheFloridianPress | Host @RightSqadPod | Co-Host @FloridaPolPod | Podcaster | Political Strategist | FL Pol | JD@TheFloridianPress.com

Feb 4, 2023, 5 tweets

πŸ‘‹#PedsGI #GITwitter
πŸ—“οΈFeb 6-Join @Subramanian1MD @valcohranmd @DCharabaty

πŸ”¦#ShortBowelSyndrome
⬆️⬇️ Safety & efficacy of med tx
πŸ”‘4 your practice

πŸ†“#CMEπŸ‘‰bit.ly/3wLGPzF
Support by an edu grant from @TakedaPharma

πŸ—³οΈ#PreConvo #IBDPollsπŸ‘‡
🟒Where are u in ur career?

#PreConvo #IBDPoll 1️⃣

πŸ†“#CMEπŸ”—bit.ly/3kN8m0Y

🟒The GLP-2 analog teduglutide was shown in clinical studies to be associated w/ which of the following outcomes?

#PreConvo #IBDPoll 2️⃣

πŸ†“#CMEπŸ”—bit.ly/3kN8m0Y

🟒Young adult pt w/ SBS is experiencing significant diarrhea (β‰₯20 BM/day) despite tx w 8 mg/day loperamide.

Appropriate mgmt includes _____

#PreConvo #IBDPoll 3⃣

πŸ†“#CMEπŸ”—bit.ly/3kN8m0Y

🟒#MedPeds pt w #ShortBowelSyndrome is being evaluated as an inpatient consult, following a recent emergency resection, w 55 cm of small bowel remaining.

Which is an appropriate initial mgmt strategy?

#PreConvo #IBDPoll 4⃣

πŸ†“#CMEπŸ”—bit.ly/3kN8m0Y

🟒Which of the following is considered to be a potentially disease-modifying treatment for pts w/ #ShortBowelSyndrome?

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling